Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Recording the reconstitution date, diluent used, calculated concentration, and storage location for every vial makes it possible to audit exactly how far into its stability window a given sample sits at the time it is used in an assay
AOD-9604 Dosage in Published Research Doses reported in the published literature are expressed in micrograms per kilogram administered subcutaneously or intraperitoneally in rodent models, and in milligrams daily in human study cohorts
Dual-mechanism advantage: GLP-1s slow digestion and increase satiety via gut hormone pathways, while Cagrilintide adds a separate amylin-driven pathway, amplifying the effect
Clinical Safety Profile of AOD-9604 in Obesity Treatment
Always follow guidance provided by your healthcare professional
US$ 28.12
US$ 21.03
US$ 23.87
US$ 24.31
US$ 20.35
US$ 22.28
US$ 21.58
US$ 25.40
US$ 20.93
